CEMI News and Press, Chembio Diagnostics Inc. From 09/09/20

Intra-Cellular Therapies (ITCI  +74%  on positive topline results from its Phase 3 clinical trial. More news on: Astrotech Corporation, Vaxart, Inc., Chembio Diagnostics, Inc., Stocks on the move, , Read more ...

HAUPPAUGE, N.Y., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its initiation of the notification process and submission of an application for Emergency Use Authori...

Gainers:  VBI Vaccines (NASDAQ: VBIV ) +35% . More news on: VBI Vaccines Inc., Rekor Systems, Inc., BMC Stock Holdings, Inc., Stocks on the move, , Read more ...

RADNOR, Pa., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP reminds Chembio Diagnostics, Inc. (NASDAQ:  CEMI) (“Chembio”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Eastern Di...

Chembio Diagnostics, Inc. (CEMI) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Philip Taylor - Investor Relations Rick Eberly - President & Chief Executive Officer Neil Goldman - Executive Vice President & Chief Financial Officer Confere...

Chembio Diagnostics (NASDAQ: CEMI ) : Q2 GAAP EPS of -$0.42 misses by $0.02 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HAUPPAUGE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended June 30, 2020. Recent Accomplishments & Highlights Anno...

FinancialBuzz.com News Commentary New York, NY (8/6/2020) – The diagnostics industry is highly diverse, with a vast number of testing methods already on the market and a consistent flow of new technologies. In fact, diagnostics are no longer just about the detection of diseases, and now...

RADNOR, PA / ACCESSWIRE / July 31, 2020 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds Chembio Diagnostics, Inc. (NASDAQ:CEMI) ("Chembio") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Chembio co...

RADNOR, Pa., July 28, 2020 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the ...